申请人:Allergan, Inc.
公开号:US05468879A1
公开(公告)日:1995-11-21
Compounds of the formula ##STR1## where R.sub.1 and R.sub.2, independently are alkyl groups having 2 to 8 carbons; R.sub.3 is hydrogen or lower alkyl; X is S, O or N--R.sub.4 where R.sub.4 is hydrogen or lower alkyl; Y is phenyl or pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, and pyrazinyl; A is (CH.sub.2).sub.n where n is 0-5, or lower branched chain alkyl, alkenyl having 2 to 6 carbons and 1 or 2 double bonds, alkynyl having 2 to 6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a salt thereof, COOR.sub.5, CONR.sub.6 R.sub.7, --CH.sub.2 OH, CH.sub.2 OR.sub.8, CH.sub.2 OCOR.sub.8, CHO, CH(OR.sub.9).sub.2, CHOR.sub.10 O, --COR.sub.11, CR.sub.11 (OR.sub.9).sub.2, or CR.sub.11 OR.sub.10 O, where R.sub.5 is alkyl of 1 to 10 carbons, or cycloalkyl of 5 to 10 carbons, or R.sub.5 is phenyl or lower alkylphenyl, R.sub.6 and R.sub.7 independently are hydrogen, alkyl of 1 to 10 carbons, or cycloalkyl of 5 to 10 carbons, or phenyl or lower alkylphenyl, R.sub.8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R.sub.9 is lower alkyl, R.sub.10 is divalent alkyl radical of 2-5 carbons and R.sub.11 is alkyl, cycloalkyl or alkenyl containing 1 to 5 carbons, have retinoic acid like activity.
具有以下结构式的化合物:##STR1##其中,R.sub.1和R.sub.2独立地是具有2到8个碳的烷基基团;R.sub.3是氢或低碳烷基;X是S,O或N--R.sub.4,其中R.sub.4是氢或低碳烷基;Y是苯基或吡啶基,噻吩基,呋喃基,吡嗪基,嘧啶基和吡嗪啉基;A是(CH.sub.2).sub.n,其中n为0-5,或低分支链烷基,具有2到6个碳和1或2个双键的烯基,具有2到6个碳和1或2个三键的炔基;B是氢,COOH或其盐,COOR.sub.5,CONR.sub.6R.sub.7,--CH.sub.2OH,CH.sub.2OR.sub.8,CH.sub.2OCOR.sub.8,CHO,CH(OR.sub.9).sub.2,CHOR.sub.10O,--COR.sub.11,CR.sub.11(OR.sub.9).sub.2,或CR.sub.11OR.sub.10O,其中R.sub.5是具有1到10个碳的烷基或具有5到10个碳的环烷基,或者R.sub.5是苯基或低碳基苯基,R.sub.6和R.sub.7独立地是氢,具有1到10个碳的烷基或具有5到10个碳的环烷基,或者是苯基或低碳基苯基,R.sub.8是具有1到10个碳的烷基,苯基或低碳基苯基,R.sub.9是低碳烷基,R.sub.10是具有2-5个碳的双价烷基基团,R.sub.11是具有1到5个碳的烷基,环烷基或烯基,具有类似于视黄酸的活性。